Cargando…
Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas
INTRODUCTION: Human epidermal growth factor receptor (HER)-2 overexpression or gene amplification is more common in high-grade or type 2 endometrial carcinomas. We assessed the discordance of HER-2 expression between primary and metastatic or recurrent endometrial carcinomas. MATERIALS AND METHODS:...
Autores principales: | Kato, Rina, Hasegawa, Kiyoshi, Ishii, Risa, Owaki, Akiko, Torii, Yutaka, Oe, Shuko, Hirasawa, Hiroshi, Kobayashi, Yoichi, Udagawa, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742156/ https://www.ncbi.nlm.nih.gov/pubmed/23950654 http://dx.doi.org/10.2147/OTT.S47504 |
Ejemplares similares
-
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
por: Birkeland, E, et al.
Publicado: (2012) -
Correlation between the overexpression of epidermal growth factor receptor and mesenchymal makers in endometrial carcinoma
por: Yang, Wei-Ning, et al.
Publicado: (2014) -
Activation of epidermal growth factor receptor results in Snail protein but not mRNA overexpression in endometrial cancer
por: Hipp, Susanne, et al.
Publicado: (2009) -
HER2 Amplification in p53-Mutated Endometrial Carcinomas
por: Balestra, Ambre, et al.
Publicado: (2023) -
Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
por: Ni, Shujuan, et al.
Publicado: (2022)